statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.069
SG - Singapore	215
CN - Cina	183
BR - Brasile	81
IT - Italia	63
DE - Germania	49
UA - Ucraina	48
GB - Regno Unito	41
HK - Hong Kong	41
SE - Svezia	35
TR - Turchia	33
VN - Vietnam	31
FI - Finlandia	20
CA - Canada	19
RU - Federazione Russa	15
IN - India	12
BE - Belgio	10
MX - Messico	10
FR - Francia	7
LT - Lituania	7
BD - Bangladesh	6
ES - Italia	6
NL - Olanda	5
AR - Argentina	4
ID - Indonesia	4
IQ - Iraq	4
PL - Polonia	4
ZA - Sudafrica	4
EG - Egitto	3
AT - Austria	2
CH - Svizzera	2
CZ - Repubblica Ceca	2
EC - Ecuador	2
JO - Giordania	2
JP - Giappone	2
PY - Paraguay	2
TW - Taiwan	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AZ - Azerbaigian	1
BN - Brunei Darussalam	1
CL - Cile	1
GY - Guiana	1
HN - Honduras	1
IR - Iran	1
JM - Giamaica	1
KE - Kenya	1
LK - Sri Lanka	1
LV - Lettonia	1
MA - Marocco	1
MD - Moldavia	1
MK - Macedonia	1
MM - Myanmar	1
NO - Norvegia	1
PK - Pakistan	1
PT - Portogallo	1
QA - Qatar	1
RO - Romania	1
SR - Suriname	1
TH - Thailandia	1
TL - Timor Orientale	1
VE - Venezuela	1
VG - Isole Vergini Britanniche	1
Totale	2.071

Nome	#
Recovery cycle of the masseter inhibitory reflex after magnetic stimulation in normal subjects	207
Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin	203
Neurophysiological study of corticomotor pathways in restless legs syndrome	201
Eccitabilità corticale motoria nella sindrome delle gambe senza riposo	183
Neurophysiological pattern in Guillain Barrè Syndrome: experience of 6 years in Ferrara	178
Bilateral striatal necrosis, dystonia and multiple mitochondrial DNA deletions: Case study and effect of deep brain stimulation	176
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test	167
Neurophysiological evaluation of the muscular hypotrophy after immobilization	149
Managing Parkinson's disease: moving ON with NOP	135
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease	111
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study	89
null	89
The Optimal Targeting for Focused Ultrasound Thalamotomy Differs between Dystonic and Essential Tremor: A 12-Month Prospective Pilot Study	74
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age	63
Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy	58
Totale	2.083

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	82	0	0	0	0	0	13	2	18	2	15	21	11
2021/2022	137	4	12	10	3	13	7	6	8	6	9	14	45
2022/2023	148	14	13	6	27	20	16	11	10	24	0	6	1
2023/2024	86	5	6	2	2	2	26	7	8	2	1	3	22
2024/2025	395	9	8	29	29	38	41	23	17	65	38	53	45
2025/2026	669	137	43	85	154	183	67	0	0	0	0	0	0
Totale													2.083

SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara